Biotech | April 25, 2022
CanSinoBIO rebrands to reflect commitment to life sciences research
This is the first major brand refresh of CanSinoBIO since its inception in 2009
This is the first major brand refresh of CanSinoBIO since its inception in 2009
Aflibercept is the second biosimilar product that has entered the clinical trial phase after biosimilar Adalimumab
Launch of novel stent technology with 10-year safety and efficacy data adds further momentum to the company's global growth journey
Both companies have been selected for stand-by production by German government
Data to be presented at the 2022 AACR annual meeting highlights the unique nature of post-chemotherapy derived gene expression signatures in stratifying patient outcomes
Makrolon polycarbonate is key to needle-free injections that can stand up to sterilization
BioFluidica LiquidScan harnesses the power of microfluidics
The aim is to pursue methylation-based tools to better understand biological reactions to pharmaceuticals
Celerity Pharmaceuticals uses Biocon Biologics’ insulin drug substance to develop the product
Shaker is one of six receiving an individual award, which recognizes people, organizations and products bringing AI to life and applying it to solve real problems
Subscribe To Our Newsletter & Stay Updated
